Yourui Pharmaceutical

Nuance Pharma, known in China as Yourui Pharmaceutical, is a leading specialty biopharmaceutical company focused on the development and commercialization of innovative therapies in the Greater China and Asia-Pacific markets. The company specializes in respiratory health, pain management, iron deficiency, and emergency care, utilizing a strategy of in-licensing late-stage clinical assets from global partners. Nuance Pharma's portfolio includes significant products such as ensifentrine for COPD, brivaracetam for epilepsy, and iron isomaltoside for anemia. With a strong emphasis on bridging the gap between global innovation and the Chinese market, the company has established robust clinical development and commercialization capabilities. Headquartered in Shanghai, Nuance Pharma is supported by a consortium of top-tier healthcare investors, including CBC Group and Matrix Partners China.